Last reviewed · How we verify
NCT03059004: TeMPO
Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis
NA trial testing TeMPO Home Exercise Program in Meniscal Degeneration in 879 participants. Completed in 1 December 2024.
1 October 2023
Quick facts
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 879 |
| Start date | 6 February 2018 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 December 2024 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- TeMPO Home Exercise Program
- Motivational SMS Messages
- In-Clinic Topical Therapy
- In-Clinic Exercise Therapy
Conditions studied
- Meniscal Degeneration — all drugs for Meniscal Degeneration →
- Osteoarthritis, Knee — all drugs for Osteoarthritis, Knee →
Sponsor
Brigham and Women's Hospital
Who can join
Adults 45 to 85, any sex, with Meniscal Degeneration or Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Knee osteoarthritis is a disabling problem affecting over 15 million adults in the United States. Many people who have knee arthritis also experience painful meniscal tears. There are a number of different treatments that can be used to manage meniscal tears in the presence of knee arthritis. Treatments include surgically removing the damaged part of the meniscus; strengthening exercises to improve pain and function; manual therapy including massage and mobilization; acupuncture; and others. The combination of surgery and exercise therapy was long thought to be the best treatment. However, recent studies have shown that surgery followed by physical therapy is no more effective than physical therapy by itself. While physical therapy alone has been shown to result in similar pain relief as arthroscopic surgery, researchers have not yet done studies to determine what type of physical therapy is best for people with knee arthritis and meniscal tears. In the "TeMPO" Trial, we will be comparing 4 different, non-operative physical therapy regimens in order to gain a better understanding of how physical therapy works and what regimen will best reduce pain and improve function in persons with meniscal tear and osteoarthritis. The four arms in this randomized trial will contain different combinations of therapeutic treatments including in-clinic therapist-supervised exercise, in-clinic topical therapies, and exercises to be completed at home. Subjects in three of the arms will also receive motivational SMS (text) messages intended to improve adherence to the home exercise regimen. TeMPO is designed as a randomized controlled trial. Participants will be assigned randomly to one of the four arms. All arms include therapies that have been previously shown to work in clinical settings. One arm also contains some placebo treatments. The placebo treatments will help us to understand what aspects of physical therapy actually make people feel better. Our hypothesis is that subjects in the arm that includes in-clinic physical therapy and a home exercise regimen will experience more pain relief than subjects in each of the other arms. Also, we expect that subjects in the arm that receives the home exercise regimen and SMS messages will experience more pain relief than subjects in the arm that receives home exercise without the SMS messages.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
A consensus-based process identifying physical therapy and exercise treatments for patients with degenerative meniscal tears and knee OA: the TeMPO physical therapy interventions and home exercise program.
Safran-Norton CE, Sullivan JK, Irrgang JJ, Kerman HM, et al · · 2019 · cited 17× · PMID 31684921 · DOI 10.1186/s12891-019-2872-x -
The TeMPO trial (treatment of meniscal tears in osteoarthritis): rationale and design features for a four arm randomized controlled clinical trial.
Sullivan JK, Irrgang JJ, Losina E, Safran-Norton C, et al · · 2018 · cited 10× · PMID 30501629 · DOI 10.1186/s12891-018-2327-9 -
A Randomized Trial of Physical Therapy for Meniscal Tear and Knee Pain.
Katz JN, Collins JE, Bisson L, Jones MH, et al · · 2025 · cited 2× · PMID 41160820 · DOI 10.1056/nejmoa2503385 -
Methodology and predictive accuracy of the prospective preference assessment for randomized trial enrollment: A literature review.
Dhani JS, Selzer F, Collins JE, Fox KB, et al · · 2025 · cited 1× · PMID 41367620 · DOI 10.1016/j.ocarto.2025.100696
Verify or expand the search:
- PubMed search for NCT03059004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
- NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
- NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
- NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
- NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
- NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03059004 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03059004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing